Cargando…
First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI)
The objective of this pilot clinical study was to assess the safety, technical feasibility, pharmacokinetic (PK) profile and tumour response of DC Bead™ with irinotecan (DEBIRI™) delivered by intra-arterial embolisation for the treatment of metastatic colorectal cancer. Eleven patients with unresect...
Autores principales: | EICHLER, K., ZANGOS, S., MACK, M.G., HAMMERSTINGL, R., GRUBER-ROUH, T., GALLUS, C., VOGL, T.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583653/ https://www.ncbi.nlm.nih.gov/pubmed/22842404 http://dx.doi.org/10.3892/ijo.2012.1572 |
Ejemplares similares
-
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study
por: Pernot, Simon, et al.
Publicado: (2020) -
Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry
por: Martin, Robert C. G., et al.
Publicado: (2009) -
Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model
por: Lewis, Andrew L., et al.
Publicado: (2012) -
The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases
por: Vogl, Thomas J., et al.
Publicado: (2022) -
Updates of colorectal cancer liver metastases therapy: review on DEBIRI
por: Fiorentini, Giammaria, et al.
Publicado: (2020)